Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations.

Volume: 8, Issue: 2, Pages: 241 - 250
Published: Nov 1, 2019
Abstract
Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to make changes to the treatment plan in order to accommodate changing circumstances. Switching drugs, or the discontinuation of immunomodulatory agents altogether, may leave patients vulnerable to relapse or disease progression. In some cases, severe MS disease activity is noted clinically and on MRI after treatment withdrawal. When this disease activity is...
Paper Details
Title
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations.
Published Date
Nov 1, 2019
Volume
8
Issue
2
Pages
241 - 250
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.